- Home
- ANIP vs AVDX Comparison
ANIP vs AVDX Comparison
Compare ANIP & AVDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIP
- AVDX
- Stock Information
- Founded
- ANIP 2001
- AVDX 2000
- Country
- ANIP United States
- AVDX United States
- Employees
- ANIP N/A
- AVDX N/A
- Industry
- ANIP Biotechnology: Pharmaceutical Preparations
- AVDX EDP Services
- Sector
- ANIP Health Care
- AVDX Technology
- Exchange
- ANIP Nasdaq
- AVDX Nasdaq
- Market Cap
- ANIP 2.0B
- AVDX 2.1B
- IPO Year
- ANIP N/A
- AVDX 2021
- Fundamental
- Price
- ANIP $91.65
- AVDX $9.95
- Analyst Decision
- ANIP Strong Buy
- AVDX Hold
- Analyst Count
- ANIP 8
- AVDX 14
- Target Price
- ANIP $93.63
- AVDX $9.73
- AVG Volume (30 Days)
- ANIP 318.4K
- AVDX 1.5M
- Earning Date
- ANIP 11-07-2025
- AVDX 11-05-2025
- Dividend Yield
- ANIP N/A
- AVDX N/A
- EPS Growth
- ANIP N/A
- AVDX N/A
- EPS
- ANIP N/A
- AVDX N/A
- Revenue
- ANIP $747,399,000.00
- AVDX $446,722,000.00
- Revenue This Year
- ANIP $39.36
- AVDX $5.52
- Revenue Next Year
- ANIP $9.45
- AVDX $9.64
- P/E Ratio
- ANIP N/A
- AVDX N/A
- Revenue Growth
- ANIP 38.68
- AVDX 8.04
- 52 Week Low
- ANIP $52.50
- AVDX $6.61
- 52 Week High
- ANIP $99.50
- AVDX $11.68
- Technical
- Relative Strength Index (RSI)
- ANIP 46.26
- AVDX 58.55
- Support Level
- ANIP $88.19
- AVDX $9.95
- Resistance Level
- ANIP $92.52
- AVDX $9.98
- Average True Range (ATR)
- ANIP 2.40
- AVDX 0.01
- MACD
- ANIP -0.93
- AVDX -0.00
- Stochastic Oscillator
- ANIP 26.50
- AVDX 60.00
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
About AVDX AvidXchange Holdings Inc.
AvidXchange Holdings Inc is a provider of AP automation software and payment solutions for middle-market businesses and their suppliers. It generates the majority of its sales from Payment revenue followed by Software revenue and Services revenue. The company generates revenue in the United States.